Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00516043
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
AGG![]() | TIROFIBAN | A,B | 2VDM | 0.72 | ![]() |
OHT![]() | 4-HYDROXYTAMOXIFEN | A | 3ERT | 0.7 | ![]() |
OHT![]() | 4-HYDROXYTAMOXIFEN | A,B | 1S9Q | 0.7 | ![]() |
OHT![]() | 4-HYDROXYTAMOXIFEN | A,B | 1VJB | 0.7 | ![]() |
OHT![]() | 4-HYDROXYTAMOXIFEN | A,B,C,P,R | 2JF9 | 0.7 | ![]() |
OHT![]() | 4-HYDROXYTAMOXIFEN | A,B,C,D,E,F | 2GPV | 0.7 | ![]() |
OHT![]() | 4-HYDROXYTAMOXIFEN | A | 2GPU | 0.7 | ![]() |
OHT![]() | 4-HYDROXYTAMOXIFEN | A | 2P7Z | 0.7 | ![]() |
OHT![]() | 4-HYDROXYTAMOXIFEN | A,B | 2BJ4 | 0.7 | ![]() |
OHT![]() | 4-HYDROXYTAMOXIFEN | A,B | 2FSZ | 0.7 | ![]() |
TRT![]() | FRAGMENT OF TRITON X-100 | A,E | 2I0U | 0.72 | ![]() |
TRT![]() | FRAGMENT OF TRITON X-100 | A,B | 1OIZ | 0.72 | ![]() |
5PP![]() | 5-PENTYL-2-PHENOXYPHENOL | A,B,C,D,E,F | 2B36 | 0.71 | ![]() |
8PS![]() | 5-OCTYL-2-PHENOXYPHENOL | A,B,C,D,E,F | 2B37 | 0.71 | ![]() |
G55![]() | (5R)-1,3-dioxepan-5-yl [(1S,2R)- 1-benzyl-2-hydroxy-3-{[(4-methoxyphenyl)sulfonyl](2- methylpropyl)amino}propyl]carbamate | A,B | 3DJK | 0.71 | ![]() |
DYY![]() | 1-[(2,6-difluorophenyl)sulfonyl]- 4-(2,3-dihydro-1,4-benzodioxin- 6-ylsulfonyl)piperazine | A,B,C,D | 3GR4 | 0.7 | ![]() |
F1N![]() | N-{1-[5-chloro-3-methoxy-2-(1-methylethoxy)benzyl]piperidin- 4-yl}-2-(2-methyl-4-sulfamoylphenoxy)acetamide | A | 2ZJN | 0.7 | ![]() |
SFX![]() | (3S)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan- 1-amine | A | 3GWW | 0.72 | ![]() |
RFX![]() | (3R)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan- 1-amine | A | 3GWV | 0.72 | ![]() |
DPD![]() | A,B | 1QIW | 0.79 | ![]() | |
DPD![]() | A | 1QIV | 0.79 | ![]() | |
RS2![]() | N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)- TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE | A | 966C | 0.7 | ![]() |
LK1![]() | N-[(6-BUTOXYNAPHTHALEN-2-YL)SULFONYL]- L-GLUTAMIC ACID | A | 2JFH | 0.76 | ![]() |
LK4![]() | N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN- 2-YL}SULFONYL)-D-GLUTAMIC ACID | A | 2UUP | 0.73 | ![]() |
LK4![]() | N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN- 2-YL}SULFONYL)-D-GLUTAMIC ACID | A | 2VTE | 0.73 | ![]() |
C4M![]() | N-[(2R,3S)-3-AMINO-2-HYDROXY-4- PHENYLBUTYL]-4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONAMIDE | B,I | 2C93 | 0.78 | ![]() |
FIN![]() | A | 1ZVX | 0.83 | ![]() | |
886![]() | N-({4'-[(4-isobutyrylphenoxy)methyl]biphenyl- 4-yl}sulfonyl)-D-valine | A,B,C,D | 2RJP | 0.76 | ![]() |
ZHH![]() | 2-(4-METHOXYPHENYL)ETHANAMINE | D,H | 2HKR | 0.71 | ![]() |
G05![]() | (4aR,6r,7aS)-hexahydro-4aH-cyclopenta[b][1,4]dioxin- 6-yl [(1S,2R)-1-benzyl-2-hydroxy- 3-{[(4-methoxyphenyl)sulfonyl](2- methylpropyl)amino}propyl]carbamate | A,B | 3DK1 | 0.72 | ![]() |
EIN![]() | A | 1ZS0 | 0.83 | ![]() | |
C5M![]() | N-{(2R,3S)-3-[(3-CHLOROBENZYL)AMINO]- 2-HYDROXY-4-PHENYLBUTYL}-4-METHOXY- 2,3,6-TRIMETHYLBENZENESULFONAMIDE | B,I | 2C8X | 0.71 | ![]() |
LK2![]() | N-[(6-BUTOXYNAPHTHALEN-2-YL)SULFONYL]- D-GLUTAMIC ACID | A | 2JFF | 0.76 | ![]() |
DZG![]() | 1-(2,3-dihydro-1,4-benzodioxin- 6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine | A,B,C,D | 3GQY | 0.73 | ![]() |
HBH![]() | 2-[(8S,11S)-11-{(1R)-1-HYDROXY- 2-[ISOPENTYL(PHENYLSULFONYL)AMINO]ETHYL}- 6,9-DIOXO-2-OXA-7,10-DIAZABICYCLO[11.2.2]HEPTADECA- 1(15),13,16-TRIEN-8-YL]ACETAMIDE | A,B | 1Z1R | 0.72 | ![]() |
CTX![]() | (Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)- PHENOXY]-N,N-DIMETHYLETHANAMINE | A,B,C | 1YA4 | 0.72 | ![]() |
CTF![]() | (17beta)-17-(cyanomethyl)-2-methoxyestra- 1(10),2,4-trien-3-yl sulfamate | A | 3BET | 0.72 | ![]() |
TXF![]() | (Z)-4-(1-{4-[2-(DIMETHYLAMINO)ETHOXY]PHENYL}- 5-HYDROXY-2-PHENYLPENT-1-ENYL)PHENOL | A,B,C,D,E | 2EWP | 0.7 | ![]() |
PO1![]() | (9BETA,13ALPHA,14BETA,17ALPHA)- 2-METHOXYESTRA-1,3,5(10)-TRIENE- 3,17-DIYL DISULFAMATE | A | 2GD8 | 0.73 | ![]() |
5RM![]() | (5R)-5-(4-methoxy-3-propoxyphenyl)- 5-methyl-1,3-oxazolidin-2-one | A,B | 1XM6 | 0.71 | ![]() |
HBB![]() | N-{(2R)-2-HYDROXY-2-[(8S,11S)-8- ISOPROPYL-6,9-DIOXO-2-OXA-7,10- DIAZABICYCLO[11.2.2]HEPTADECA-1(15),13,16- TRIEN-11-YL]ETHYL}-N-ISOPENTYLBENZENESULFONAMIDE | A,B | 1Z1H | 0.74 | ![]() |
BZN![]() | N-({(3R,4R)-4-[(benzyloxy)methyl]pyrrolidin- 3-yl}methyl)-N-(2-methylpropyl)benzenesulfonamide | B | 3BHE | 0.71 | ![]() |
TAX![]() | (Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)- PHENOXY]-N,N-DIMETHYLETHANAMINIUM | A | 1FJ5 | 0.74 | ![]() |
F1M![]() | N-{1-[5-chloro-3-methoxy-2-(1-methylethoxy)benzyl]piperidin- 4-yl}-2-(4-sulfamoylphenoxy)acetamide | A | 2ZJM | 0.71 | ![]() |
MZ9![]() | N-[(1S,2R)-1-BENZYL-2-HYDROXY-3- {[(4-METHOXYPHENYL)SULFONYL][(2S)- 2-METHYLBUTYL]AMINO}PROPYL]-4-OXOHEXANAMIDE | A,B | 2QI7 | 0.72 | ![]() |
MBS![]() | A,B | 1HY7 | 0.78 | ![]() | |
MUU![]() | N-[(1S,2R)-1-BENZYL-3-{(CYCLOPROPYLMETHYL)[(3- METHOXYPHENYL)SULFONYL]AMINO}-2- HYDROXYPROPYL]-N'-METHYLSUCCINAMIDE | A,B | 2PSU | 0.72 | ![]() |
ROL![]() | ROLIPRAM | A,B,C,D | 1OYN | 0.72 | ![]() |
ROL![]() | ROLIPRAM | A,B | 1XMY | 0.72 | ![]() |
ROL![]() | ROLIPRAM | A,B,C,D | 1Q9M | 0.72 | ![]() |
ROL![]() | ROLIPRAM | A,B | 1RO6 | 0.72 | ![]() |
ROL![]() | ROLIPRAM | A,B | 1XN0 | 0.72 | ![]() |
ROL![]() | ROLIPRAM | A,B | 1TBB | 0.72 | ![]() |
AL9![]() | N-[(4-METHOXYPHENYL)METHYL]2,5- THIOPHENEDESULFONAMIDE | A | 1BN4 | 0.72 | ![]() |
189![]() | N-BENZYL-2-(2,6-DIMETHYLPHENOXY)- N-[((3R,4S)-4-{[ISOBUTYL(PHENYLSULFONYL)AMINO]METHYL}PYRROLIDIN- 3-YL)METHYL]ACETAMIDE | A,B | 1XL2 | 0.74 | ![]() |
LK3![]() | N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}- D-GLUTAMIC ACID | A | 2UUO | 0.76 | ![]() |
Y12![]() | 4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP- 1-EN-1-YL}-1,2-PHENYLENE DIACETATE | A | 2EW5 | 0.73 | ![]() |
4SR![]() | (4S)-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]PYRROLIDIN- 2-ONE | A,B | 1XN0 | 0.72 | ![]() |
LKM![]() | N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN- 2-YL}SULFONYL)-D-GLUTAMIC ACID | A | 2VTD | 0.72 | ![]() |